Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Adv Sci (Weinh)
1 Asia Pac J Clin Oncol
1 Cancer Discov
1 Cancer Med
1 Cell Oncol (Dordr)
1 Cell Physiol Biochem
1 Clin Cancer Res
1 Curr Oncol Rep
1 Curr Urol Rep
1 Diabetes Res Clin Pract
1 Drug Des Devel Ther
1 EBioMedicine
1 Eur J Pharm Biopharm
1 Eur J Surg Oncol
1 Eur Urol
1 Int J Radiat Oncol Biol Phys
1 J Agric Food Chem
1 J Cancer Res Clin Oncol
1 J Clin Lab Anal
1 J Int Med Res
1 JAMA Surg
1 Neoplasma
1 Onco Targets Ther
1 Oncogene
1 PLoS One
2 Rev Urol
1 Turk J Urol
5 World J Urol

    Adv Sci (Weinh)

  1. GUO H, Li F, Xu W, Chen J, et al
    Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer.
    Adv Sci (Weinh). 2018;5:1800004.
    >> Share

    Asia Pac J Clin Oncol

  2. MI Y, Zhao Y, Shi F, Zhang M, et al
    Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
    Asia Pac J Clin Oncol. 2018 Jun 22. doi: 10.1111/ajco.13024.
    >> Share

    Cancer Discov

  3. Erdafitinib Efficacious in Bladder Cancer.
    Cancer Discov. 2018 Jun 27. pii: 2159-8290.CD-NB2018.
    >> Share

    Cancer Med

  4. LIN N, Wu YP, Lin YZ, Tao X, et al
    Risk factors for upper tract urothelial recurrence following local excision of bladder cancer.
    Cancer Med. 2018 Jun 28. doi: 10.1002/cam4.1642.
    >> Share

    Cell Oncol (Dordr)

  5. DUDEK AM, Vermeulen SH, Kolev D, Grotenhuis AJ, et al
    Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
    Cell Oncol (Dordr). 2018 Jun 28. pii: 10.1007/s13402-018-0393.
    >> Share

    Cell Physiol Biochem

  6. WANG J, Fang R, Wang L, Chen G, et al
    Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.
    Cell Physiol Biochem. 2018;47:1565-1577.
    >> Share

    Clin Cancer Res

  7. LELO A, Prip F, Harris BT, Solomon D, et al
    STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2018 Jun 28. pii: 1078-0432.CCR-17-3244.
    >> Share

    Curr Oncol Rep

    Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Curr Oncol Rep. 2018;20:66.
    >> Share

    Curr Urol Rep

    Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma.
    Curr Urol Rep. 2018;19:11.
    >> Share

    Diabetes Res Clin Pract

  10. DAVIDSON MB, Pan D
    Erratum to "An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis" [Diab. Res. Clin. Pract. 135 (2018) 102-110].
    Diabetes Res Clin Pract. 2018 Jun 20. pii: S0168-8227(18)30968.
    >> Share

    Drug Des Devel Ther

  11. BOURN J, Cekanova M
    Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
    Drug Des Devel Ther. 2018;12:1727-1742.
    >> Share


  12. YANG Z, Zhang R, Ge Y, Qin X, et al
    Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.
    EBioMedicine. 2018 Jun 22. pii: S2352-3964(18)30218.
    >> Share

    Eur J Pharm Biopharm

  13. APFELTHALER C, Skoll K, Ciola R, Gabor F, et al
    A Doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.
    Eur J Pharm Biopharm. 2018 Jun 27. pii: S0939-6411(18)30082.
    >> Share

    Eur J Surg Oncol

  14. VOSKUILEN CS, Fransen van de Putte EE, Perez-Reggeti JI, van Werkhoven E, et al
    Prostate sparing cystectomy for bladder cancer: A two-center study.
    Eur J Surg Oncol. 2018 Jun 8. pii: S0748-7983(18)31115.
    >> Share

    Eur Urol

  15. THOENY HC, Bellin MF, Comperat EM, Thalmann GN, et al
    Vesical Imaging-Reporting and Data System (VI-RADS): Added Value for Management of Bladder Cancer Patients?
    Eur Urol. 2018 Jun 27. pii: S0302-2838(18)30442.
    >> Share

    Int J Radiat Oncol Biol Phys

  16. TANAKA H, Yoshida S, Koga F, Toda K, et al
    Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Jun 27. pii: S0360-3016(18)31021.
    >> Share

    J Agric Food Chem

  17. XIA Y, Yuan M, Li S, Thuan UT, et al
    Apigenin suppresses IL-1beta-induced expression of urokinase-type plasminogen activator receptor by inhibiting MAPK-mediated AP-1 and NF-small ka, CyrillicB signaling in human bladder cancer T24 cells.
    J Agric Food Chem. 2018 Jun 27. doi: 10.1021/acs.jafc.8b02351.
    >> Share

    J Cancer Res Clin Oncol

  18. RINALDETTI S, Wirtz R, Worst TS, Hartmann A, et al
    FOXM1 predicts disease progression in non-muscle invasive bladder cancer.
    J Cancer Res Clin Oncol. 2018 Jun 29. pii: 10.1007/s00432-018-2694.
    >> Share

    J Clin Lab Anal

  19. BEN WAFI S, Kallel A, Ben Fradj MK, Sallemi A, et al
    Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.
    J Clin Lab Anal. 2018 Jun 29:e22610. doi: 10.1002/jcla.22610.
    >> Share

    J Int Med Res

  20. ZHOU X, Ji H, Zhang H, Xiong T, et al
    Treatment and outcomes of urethral recurrence after orthotopic neobladder replacement in patients with bladder cancer - practice in a single centre.
    J Int Med Res. 2018 Jan 1:300060518782015. doi: 10.1177/0300060518782015.
    >> Share

    JAMA Surg

  21. WILLIAMS SB, Shan Y, Jazzar U, Mehta HB, et al
    Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    JAMA Surg. 2018 Jun 27. pii: 2685879. doi: 10.1001/jamasurg.2018.1680.
    >> Share


  22. FENG SQ, Zhang XY, Fan HT, Sun QJ, et al
    Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Neoplasma. 2018 Jun 26. doi: 10.4149/neo_2018_180125.
    >> Share

    Onco Targets Ther

  23. LI J, Cheng Y, Liu G, Ji Z, et al
    The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis.
    Onco Targets Ther. 2018;11:3449-3459.
    >> Share


  24. PENG M, Wang J, Zhang D, Jin H, et al
    PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.
    Oncogene. 2018 Jun 21. pii: 10.1038/s41388-018-0374.
    >> Share

    PLoS One

  25. BECKFORD VERA DR, Smith CC, Bixby LM, Glatt DM, et al
    Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
    PLoS One. 2018;13:e0193832.
    >> Share

    Rev Urol

    Management of Recurrent Non-Muscle Invasive Bladder Cancer.
    Rev Urol. 2018;20:38-40.
    >> Share

    Bladder Cancer Academy 2018 Selected Summaries.
    Rev Urol. 2018;20:31-37.
    >> Share

    Turk J Urol

  28. ISLAMOGLU E, Anil H, Erol I, Tas S, et al
    Robotic radical cystectomy for the management of bladder cancer: Analysis of operative and pathological outcomes of eighteen patient.
    Turk J Urol. 2018;44:311-315.
    >> Share

    World J Urol

  29. SORIA F, Droller MJ, Lotan Y, Gontero P, et al
    An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.
    World J Urol. 2018 Jun 21. pii: 10.1007/s00345-018-2380.
    >> Share

  30. GARCIA-PERDOMO HA, Montes-Cardona CE, Guacheta M, Castillo DF, et al
    Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.
    World J Urol. 2018 Jun 25. pii: 10.1007/s00345-018-2384.
    >> Share

  31. KRABBE LM, Margulis V, Schrader AJ, Shariat SF, et al
    Molecularly-driven precision medicine for advanced bladder cancer.
    World J Urol. 2018 Jun 8. pii: 10.1007/s00345-018-2354.
    >> Share

  32. RINGUETTE-GOULET C, Bolduc S, Pouliot F
    Modeling human bladder cancer.
    World J Urol. 2018 Jun 14. pii: 10.1007/s00345-018-2369.
    >> Share

  33. FLETCHER SA, Harmouch SS, Krimphove MJ, Cole AP, et al
    Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.
    World J Urol. 2018 Jun 14. pii: 10.1007/s00345-018-2371.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016